Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 11, 2022

Total Value ($000): $735,310 (100.0% shares, 0.0% debt)

Holdings (7)

— NGM Biopharmaceuticals Inc 37.1%

Value ($000) $272,665 Shares 15,396,116 Est. Cost $30.30 Unrealized —

TNYA Tenaya Therapeutics, Inc. 24.2%

Value ($000) $178,135 Shares 9,400,290 Est. Cost $21.49 Unrealized +1.4%

RVMD Revolution Medicines Inc 11.5%

Value ($000) $84,250 Shares 3,347,245 Est. Cost $39.54 Unrealized -28.7%

— Surrozen, Inc. 8.2%

Value ($000) $60,631 Shares 9,414,795 Est. Cost $7.07 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 7.1%

Value ($000) $52,452 Shares 3,568,181 Est. Cost $28.69 Unrealized -45.7%

— RAPT Therapeutics Inc 7.0%

Value ($000) $51,496 Shares 1,402,008 Est. Cost $19.75 Unrealized —

— eFFECTOR Therapeutics Inc 4.9%

Value ($000) $35,681 Shares 4,309,329 Est. Cost $14.05 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	NGM Biopharmaceuticals Inc	15,396,116	$272,665	37.1%	$30.30	—	COM	62921N105
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$178,135	24.2%	$21.49	+1.4%	COM	87990A106
RVMD	Revolution Medicines Inc	3,347,245	$84,250	11.5%	$39.54	-28.7%	COM	76155X100
—	Surrozen, Inc.	9,414,795	$60,631	8.2%	$7.07	—	COM	86889P109
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$52,452	7.1%	$28.69	-45.7%	COM	68622P109
—	RAPT Therapeutics Inc	1,402,008	$51,496	7.0%	$19.75	—	COM	75382E109
—	eFFECTOR Therapeutics Inc	4,309,329	$35,681	4.9%	$14.05	—	COM	28202V108